We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Multichannel Pipette Facilitates High-Throughput RNA Isolation

By LabMedica International staff writers
Posted on 13 Jun 2013
A new advanced multichannel pipette facilitates procedures such as a solid phase extraction-microplate method for reproducible, high throughput isolation of high quality, DNA-free total RNA.

Integra Biosciences (Zizers, Switzerland and Hudson, NH, USA) introduces the use of its new VIAFLO 384 electronic 384-channel pipette for procedures such as the high throughput isolation of total RNA. More...
VIAFLO 384, an advanced version of Integra’s VIAFLO 96, is capable of both 96- and 384-channel pipetting via interchangeable heads, offering the benefits of an increased sample throughput option as well as lower sample and reagent use without the high expense of investing in a robotic liquid handling system. Designed to be used like a standard handheld pipette, the VIAFLO 384 requires no specialized skills or training for operation. It is also benchtop sized and can fit into laminar flow hoods.

VIAFLO 384 (and VIAFLO 96) is hand guided but movements are assisted by motors, enabling effortless and precise workflow. Pushing in one direction steers the pipetting head, making VIAFLO 384/96 intuitive to operate and freeing staff from training time. The VIAFLO 384 also features Integra’s popular “Touch Wheel” pipette-user interface, enabling simple and fast programming of a wide range of pipetting modes, including repeat dispense, serial dilute, and mixing routines. Up to 10 predefined pipetting modes are available to minimize set up time; alternatively, personalized custom programs can be created to suit diverse application needs.


Large-scale gene expression screening projects require reliable high-throughput methods to isolate high quality RNA from a large number of samples. To meet this need, a growing number of 96-well format RNA isolation kits are commercially available and are typically compatible with commonly used 96-well plate vacuum manifolds enabling the RNA extraction procedure to be accelerated. The video shows the use of the VIAFLO 384 handheld electronic pipette in conjunction with vacuum manifold, 96-well solid phase extraction (SPE) microplate, and RNA isolation kit to reproducibly extract high quality total RNA from cells.


Related Links:
Integra Biosciences


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.